US Environmental Protection Agency
Office of Pesticide Programs

Office of Pesticide Programs

Microbiology Laboratory

Environmental Science Center, Ft. Meade, MD

Standard Operating Procedure for
Production and Storage of Spores of Clostridioides
difficile for Use in the Efficacy Evaluation of
Antimicrobial Agents

SOP Number: MB-28-08

Date Revised: 09-20-22


-------
SOP No. MB-28-08
Date Revised 09-20-22
Page i of 18

SOP Number

MB-28-08

Title

Production and Storage of Spores of Clostridioides difficile for Use
in the Efficacy Evaluation of Antimicrobial Agents

Revisions Made

•	Minor editorial changes for clarification purposes.

•	Added language in carriers section; the top of the disk is brushed
and has round edges (Section 11.1 .q.i).

•	When preparing mucin, it is now passed through a 0.2 |im pore
diameter membrane filter instead of autoclaved (Section 11.2.1 .iii).

•	Removed footnotes stating additional confirmatory procedures not
prescribed in ASTM E2839-18.

•	Updated ASTM International Standard reference from 2018 to
2021 and updated version number from E2839-18 to E2839-21.


-------
SOP No. MB-28-08
Date Revised 09-20-22
Page 1 of 18

SOP Number

MB-28-08

Title

Production and Storage of Spores of Clostridioides difficile for Use
in the Efficacy Evaluation of Antimicrobial Agents

Scope

This document specifies the procedures for producing and storing
standardized suspensions of Clostridioides difficile spores based on
ASTM E2839-21.

Application

For use in the evaluation of sporicidal activity of antimicrobial
formulations using the Quantitative Method for Testing
Antimicrobial Agents against Spores of C. difficile on Hard, Non-
Porous Surfaces or other procedures.





Approval

Date

SOP Developer



09/20/22



Print Name: Lisa Smith

SOP Reviewer



09/20/22



Print Name: Rebecca Pines

Quality Assurance Unit



09/20/22



Print Name: Michele Cottrill

Branch Chief



09/20/22



Print Name: Rebecca Pines



Date SOP issued:

09/20/22

Controlled copy
number:

0

Date SOP withdrawn:




-------
SOP No. MB-28-08
Date Revised 09-20-22
Page 2 of 18

TABLE OF CONTENTS
Contents	Page Number

1.

DEFINITIONS

3

2.

HEALTH AND SAFETY

3

3.

PERSONNEL QUALIFICATIONS AND TRAINING

3

4.

INSTRUMENT CALIBRATION

3

5.

SAMPLE HANDLING AND STORAGE

3

6.

QUALITY CONTROL

3

7.

INTERFERENCES

3

8. NON-CONFORMING DATA

3

9.

DATA MANAGEMENT

4

10.

CAUTIONS

4

11.

SPECIAL APPARATUS AND MATERIALS

4

12.

PROCEDURE AND ANALYSIS

7

13.

DATA ANALYSIS/CALCULATIONS

15

14.

FORMS AND DATA SHEETS

15

15.

REFERENCES

15


-------
SOP No. MB-28-08
Date Revised 09-20-22
Page 3 of 18

1. Definitions

1.	Additional abbreviations/definitions are provided in the text.

2.	Pre-reduced medium: an agar or broth manufactured in an oxygen-free
environment and packaged in air-tight sealed pouches or bags.

3.	Density gradient medium: HistoDenz™ is a non-ionic gradient
medium used here to separate spores from vegetative cells and cell
fragments on the basis of density.

4.	Purified spores: level of quality based on when the spore concentration
reaches >95%, as vegetative cells and cell fragments are separated by
the density gradient medium.

5.	Toxigenic strain: possesses either toxin A gene (tcdA+) or toxin B gene
(tcdB+) or both.

2. Health and Safety

Follow procedures specified in SOP MB-01, Laboratory Biosafety. The
Study Director and/or lead analyst should consult the Safety Data Sheet for
specific hazards associated with chemicals.

3. Personnel

Qualifications and
Training

Refer to SOP ADM-04, OPP Microbiology Laboratory Training.

4. Instrument
Calibration

Refer to SOP EQ-01 (pH meters), EQ-02 (thermometers and hygrometers),
EQ-03 (weigh balances), EQ-05 (timers), and QC-19 (pipettes) for details
on method and frequency of calibration.

5. Sample Handling
and Storage

Not applicable

6. Quality Control

1.	For quality control purposes, document the required information on the
appropriate form(s) (see section 14).

2.	Refer to SOP MB-10, Media and Reagents Preparation and Quality
Evaluation, for QC of media and reagents.

7. Interferences

The test organism must be incubated under strict anaerobic conditions. If
an anaerobic environment is not maintained, the presence of oxygen will
compromise the viability of C. difficile.

8. Non-conforming
Data

1. The acceptance criteria for a spore suspension are: (1) spore titer of
approximately 5.0xl08 spores/mL, (2) spore purity of >95%, and (3) a
mean logio reduction (LR) value >5.0 for 3 carriers exposed to 5,000
ppm and a mean LR of <3.0 for 3 carriers exposed to 1,500 ppm
sodium hypochlorite. These acceptance criteria are necessary in order
to use the spore suspension to evaluate the performance of
antimicrobial formulations using SOP MB-31, Quantitative Method for


-------
SOP No. MB-28-08
Date Revised 09-20-22
Page 4 of 18



Testing Antimicrobial Agents against Spores of C. difficile on Hard,
Non-porous Surfaces.

2. Management of non-conforming data will be consistent with SOP
ADM-07, Non-Conformance Reports.

9. Data Management

Archive the data consistent with SOP ADM-03, Records and Archives.

10. Cautions

1.	Seal culture plates with Parafilm™, or equivalent, to prevent
dehydration during the extended anaerobic incubation.

2.	Ensure media (e.g.. Reinforced clostridial medium) is pre-reduced for
at least 24±2 h prior to use.

3.	Place inoculated plates under anaerobic conditions within 1 hour of
opening the sealed package of plates.

11. Special Apparatus
and Materials

1. Apparatus.

a.	Calibratedmicropipettes (e.g., 200 |iL, 1000 |iL). 1000 |iL
pipettes with corresponding tips for transferring reagents and
spores. 200 |iL pipettes with corresponding tips for deposition of
test substance on carrier.

b.	Sterile centrifuge tubes. Polypropylene, 15 niL and 50 niL
graduated plastic centrifuge tubes with conical bottoms.

c.	Microcentrifuge tubes. Siliconized, sterile 1.5-mL low-retention
microcentrifuge tubes. Use for dilutions and processing of spores
during purification.

d.	Centrifuge with swinging-bucket rotor. To allow sedimentation of
spores for washing and/or concentration.

e.	Microcentrifuge. To allow sedimentation of spores for washing
and/or concentration.

f.	Inoculating loop. 10 |iL loop to streak plates.

g.	Vortex mixer.

h.	Poly ethersulfone membrane filter (PES). For recovery of test
spores, 47 mm diameter and 0.2 |im pore size. Use any filtration
apparatus including filtration units (reusable or disposable).

i.	Anaerobic chamber. Supported by a gas mixture containing at
least 5% Eh with the balance comprising any inert gas such as
CO2, N2, or Ar; refer to chamber manufacturer's
recommendations. Alternatively, an activated anaerobic jar can be
used according to manufacturer's instructions for ensuring an


-------
SOP No. MB-28-08
Date Revised 09-20-22
Page 5 of 18

anaerobic environment.

j. Incubator. Use an incubator at 36±1°C inside an anaerobic
chamber to support the growth of the organism. Alternatively,
place the anaerobic jars in an aerobic incubator at 36±1°C.

k. Microscope with 1 OX eyepiece and 100X (oil) objective with
phase contrast option. To evaluate purity of spore suspension.

1. Timer. Any timer that can display time in seconds.

m. Cell scraper spreader. To aid in the removal of spores from agar
plates.

n. Laboratory film (or scalable bag). To seal inoculated plates
during extended incubation (>48 h).

o. Refrigerator (2-8°C). For short term storage of spore suspension
during the purification process.

p. Freezer (~80±5°C). For long term storage of stock cultures and
spore suspensions.

q. Carriers. For use in spore qualification using NaOCl.

i. Disks (1 cm in diameter) made of AISI Type 304 Stainless
Steel with 150 grit unidirectional finish on one side (top).
The top of the disk is brushed and has rounded edges; only
the top is visually screened and inoculated. Carriers are
single-use only. See MB-31 for complete carrier
specifications and photographs of screened carriers.

r. Calibrated 10 piL positive displacement pipette with
corresponding 10 piL tips. For carrier inoculation.

s. Bottle-top dispensers, squirt bottles, pre-measured volumes in
tubes, or pipettes. For rinsing vials and filters.

t. Sterile forceps. To handle membrane filters and to pick up the
carriers for placement in vials.

u. Filter paper. 150 mm diameter, to line Petri plates.

v. Sterile vials with lids (plastic or comparable). For holding
inoculated carriers to be exposed to the test chemical and for
accommodating neutralizers. Flat-bottomed and wide-mouthed to
accommodate addition and removal of the carriers. Use vials at
least 25 mm in neck diameter and capable of holding at least 20
mL of liquid.


-------
SOP No. MB-28-08
Date Revised 09-20-22
Page 6 of 18

w. Desiccator (with gauge to measure vacuum) with fresh desiccant
(e.g., CaCOs). For drying the inoculum on the carriers.

x. Vacuum source: In-house line or suitable vacuum pump (20-25 in
mercury, 0.068 to 0.085 MPa) for drying carriers and for filtering.

y. Digital titrator kit. To measure total chlorine. Alternate titration
methods may be used.

2. Media and Reagents

a.	Reinforced clostridial medium (RCM). For use in rehydrating
lyophilized/frozen vegetative culture of C. difficile. Prepare RCM
according to manufacturer's instructions and pre-reduce in an
anaerobic environment for at least 24±2 h prior to use.

b.	RCM plus 15% glycerol (cryoprotectant). For use as the
cryopreservation medium for vegetative frozen stock (VFS)
cultures. Prepare RCM and add 15% (v/v) glycerol, autoclave for
20 min at 121 °C; pre-reduce in an anaerobic environment for at
least 24±2 h prior to use.

c.	CDC anaerobic 5% sheep blood agar (CABA). Sporulation
medium commercially available pre-reduced (e.g.. Anaerobe
Systems, Morgan Hill, CA, or equivalent).

d.	Recovery media for enumeration of viable spores. Pre-reduced
brain-heart infusion agar with yeast extract, horse blood and
sodium taurocholate (BHIY-HT), commercially available pre-
reduced (e.g.. Anaerobe Systems, Morgan Hill, CA, or
equivalent).

e.	Phosphate buffered saline (PBS). For use as a rinsing agent and to
prepare PBS containing 0.1% (v/v) Tween-80 (PBS-T) and PBS-T
with 0.1%) (w/v) sodium thiosulfate; PBS pH is 7.0±0.5.

f.	PBS containing 0.1% (v/v) Tween 80 (PBS-T). Diluting and
washing reagent; PBS-T pH is 7.2±0.2.

g.	PBS-T with 0.1% (w/v) sodium thiosulfate. Neutralizer for sodium
hypochlorite-based test chemicals; PBS-T pH is 7.2±0.2.

h.	Water. Use either deionized distilled water or water with
equivalent quality for making reagent solutions and culture media.

i.	Reagent-grade sodium hypochlorite (NaOCl) with total chlorine
>4%. Use to prepare 5,000±250 ppm and 1,500±150 ppm total
chlorine solutions to qualify spores.


-------
SOP No. MB-28-08
Date Revised 09-20-22
Page 7 of 18



j. Tween-80 (polysorbate 80). Use to prepare PBS-T.

k. HistoDenz™. Use as a density gradient medium for spore

purification. Prepare a 50% (w/v) solution in deionized water.

Pass the solution through a sterile 0.45 urn filter to sterilize. Store

at 2-5°C.

1. Soil load. Use in assay to qualify spore suspension. Soil load is a
mixture of the following stock solutions:

i.	Bovine serum albumin (BSA): Add 0.5 g BSA (radio
immunoassay (RIA) grade or equivalent) to 10 mL of
PBS, mix, and pass through a 0.2 |im pore diameter
membrane filter to sterilize.

ii.	Yeast extract: Add 0.5 g yeast extract to 10 mL of PBS,
mix, and pass through a 0.2 |im pore diameter membrane
filter to sterilize.

iii.	Mucin: Add 0.04 g mucin (from bovine submaxillary
gland or equivalent) to 10 mL of PBS, mix thoroughly
until dissolved, and pass through a 0.2 |im pore diameter
membrane filter.

iv.	Aseptically aliquot soil stock solutions and store for up to
one year at -20±5°C. The stock solutions of the soil load
are single use only; do not refreeze once thawed. Other
volumes of the stock solutions may be prepared following
the same ratio.

2. Test Organism

a. Clostridioides difficile (ATCC 43598), formerly known as

Clostridium difficile, a toxigenic strain (tcdA-, tcdB+), obtained
from a reputable vendor. The strain produces only Toxin B
(presence of tcdB gene by PGR). The organism is a Gram-
positive, strictly anaerobic, spore-forming bacterium that produces
flat, gray, irregular colonies on the surface of CAB A plates within
48 h at 36±1°C.

12. Procedure and
Analysis

In brief, the method provides detailed instructions for the culture,
maintenance, sporulation and storage of C. difficile spores. Purified spores
are enumerated and assessed for quality using a carrier-based test
employing two concentrations of sodium hypochlorite (NaOCl).

12.1 Preparation of
Frozen Stock
Cultures of Test

a. C. difficile received in lyophilized vegetative form:

i. In an anerobic environment, reconstitute contents of the
lyophilized culture with 0.5 mL of sterile pre-reduced


-------
SOP No. MB-28-08
Date Revised 09-20-22
Page 8 of 18

Organism
(Vegetative Form)



ii.

RCM according to the manufacturer's instructions.

After rehydration, aseptically transfer the vial contents to a
tube containing 4± 1 niL of pre-reduced RCM and mix by
gentle vortexing.



b.

C. difficile received as frozen vegetative culture:





i.

Thaw frozen culture at room temperature.





ii.

In an anaerobic environment, transfer the contents to a
tube containing 4± 1 niL of sterile pre-reduced RCM and
mix by gentle vortexing.



c.

Inoculation of CABA Plates for Vegetative Stock Culture:





i.

Spread plate 100 |iL of the reconstituted culture in RCM
on each of five C AB A plates.





ii.

Streak one CABA plate for isolation to check for culture
purity.





iii.

Invert plates and incubate anaerobically at 36±1°C for
48±4 h. Observe CABA plate for purity and characteristics
of C. difficile; discard the C AB A plates if not pure and
reinitiate a new stock culture.



d.

Harvest of CABA Plates for Stock Culture:





i.

Following incubation (12.1 c.iii), add approximately 2 niL
of sterile and cryoprotectant (11.2.b) to each C AB A plate.





ii.

Using a sterile cell scraper, gently scrape culture from the
surface of one plate, aspirate with a pipette and transfer to
a 15 niL conical tube. Repeat this process for the
remaining plates.





iii.

Pool the suspensions, mix thoroughly, and pipette
approximately 0.4±0. lmL aliquots into cryovials; cap
tightly.





iv.

Store the cryovials at -80±5CC. These vials contain the
Vegetative Frozen Stock (VFS) Culture.



e.

Evaluation of Vegetative Frozen Stock:





i.

Within 2-7 days after freezing, thaw a VFS cryovial at
room temperature, preferably under anaerobic conditions.
If processing under aerobic conditions, perform steps
12. le, i - 12. le, iv within 15 min.


-------
SOP No. MB-28-08
Date Revised 09-20-22
Page 9 of 18



ii.	Vortex suspension thoroughly for at least 30±5 s and
serially dilute 0.1 niL out to 10"6 in PBS-T.

iii.	Spread-plate 100 |iL from 10"5 and 10"6 dilution tubes in
duplicate on BHIY-HT.

iv.	Invert plates and incubate anaerobically at 36±1°C for
48±4 h. Record the number of colony forming units (CFU)
per plate and determine the CFlJ/mL. The titer should be
>1.0><108 CFlJ/mL. Discard the VFS and reinitiate if the
titer is <108 CFlJ/mL. If the titer is appropriate, use the
frozen VFS cultures for a maximum of 18 months then
reinitiate using a new lyophilized culture.

v.	Note: New VFS cultures may be initiated one time using
an existing, unexpired frozen stock culture.

12.2 Preparation of a
test spore
suspension from
VFS

a.	Inoculation of CAB A plates. Thaw a VFS cryovial at room
temperature. Streak three CAB A plates with the VFS, preferably
under anaerobic conditions.

i.	Initiate anaerobic incubation for two plates and aerobic
incubation for one plate at 36±1°C for 48±4 h within 15
min of removing the VFS cryovial from storage.

ii.	Inspect plates incubated anaerobically for purity and
colony characteristics typical of C. difficile. Do not use the
culture if there is uncharacteristic growth on any plate, or
if there is any growth on the plate incubated aerobically.
Record observations on the C. difficile Spore Suspension
Initiation Processing Sheet (see section 14).

b.	Using one of the two anaerobic plates, inoculate 10 niL of pre-
reduced RCM with an isolated colony and mix well by vortexing.
Incubate anaerobically at 36±1°C for 24±2 h.

c.	Vortex the RCM broth culture and use 100 |iL to inoculate each
of ten CAB A plates. Spread the inoculum evenly over the plate
using a disposable sterile spreader to create a lawn.

d.	Seal inoculated plates with laboratory film to prevent dehydration
during anaerobic incubation in an anaerobic chamber. Invert
plates and incubate anaerobically for 10 days at 36±1°C and
approximately 70% relative humidity. Maintenance of relative
humidity is not required if an anaerobic jar is used.

i. Inspect one plate within 72 h of incubation to verify the
presence of a lawn (confluent growth on the plate). If


-------
SOP No. MB-28-08
Date Revised 09-20-22
Page 10 of 18

growth is confluent, reseal the plate and continue
incubation. Record observations.

e.	Following the 10-day incubation period, transfer the CAB A plates
to a biological safety cabinet. Prepare wet-mount samples of C.
difficile from a CAB A plate and inspect under phase-contrast
microscopy. Spores appear bright and ovular, while vegetative
cells appear dark and rod-shaped. Degree of conversion of
vegetative cells to spores should be approximately 90% (see
Attachment 1); if below approximately 90%, discard the
inoculated plates and initiate a new culture (12.2.a).

f.	Harvesting CABA plates. Harvest growth from each plate by
adding 5 niL of PBS-T to each plate. Gently scrape the surface of
the plate with a cell scraper or spreader to dislodge the spores. Do
not break the surface of the agar.

g.	Using a 10 niL sterile serological pipette, aspirate as much of the
suspension as possible from each plate, pool it in a sterile 50 niL
plastic conical tube, and mix well by thorough vortexing. Divide
the suspension evenly into two 50 niL conical tubes. Mix well by
thorough vortexing.

h.	Washing the spore suspension by centrifugation. Centrifuge tubes
from 12.2g at 4,500 g for 15 min.

i.	Discard the supernatant and resuspend the pellets with 30 niL of
PBS-T per tube. Cap the tubes tightly and disaggregate the pellets
by thorough vortexing. This step is the first wash. Centrifuge
tubes at 4,500 g for 15 min.

j. Discard the supernatant and resuspend the pellets with 30 niL of
PBS-T. Cap the tubes tightly and disaggregate the pellets by
thorough vortexing. This step is the second wash. Centrifuge
tubes at 4,500 g for 15 min. After the second wash, discard the
supernatant and resuspend the pellets of one of the 50 niL conical
tubes with 30 niL of PBS-T. Mix well by vortexing. Add the
contents of the first tube to the second 50 niL conical tube. Mix
well by thorough vortexing. This step is the third wash.

Centrifuge tube at 4,500 g for 15 min.

k. After the third wash, discard the supernatant and resuspend the
pellet in 4 niL of PBS-T. Mix well by vortexing to disaggregate
the pellet.


-------
SOP No. MB-28-08
Date Revised 09-20-22
Page 11 of 18



Note: For every 10 CAB A plates inoculated, the resulting pellet is
resuspended in 4 mL of PBS-T. Follow the ratio (4 mL per 10
plates) if additional plates are harvested.

1. Heat treatment. Heat the spore suspension in a heat block for 10=1=1
min at 65±2°C. To ensure that the spore suspension has reached
65±2°C, place a thermometer in an identical tube containing the
same volume of PBS-T alongside the spore suspension (ensure
that the thermometer is centered in the PBS-T and that the top of
this tube is sealed around the thermometer) and start the timer
once the temperature of the PBS-T in tube has reached 65±2°C.

m. Following the heat treatment, allow the suspension to cool to
room temperature.

n. Microscopic evaluation of spore suspension. Mix the spore
suspension (12.2.m) by vortexing and prepare a wet-mount.
Observe at least five fields using a phase-contrast microscope.
The percent of spores to vegetative cells should be >90%.

o. Evaluate titer of the spore suspension. Mix the spore suspension
vigorously by vortexing (30±5 s) prior to taking an aliquot of the
spore suspension (e.g., 10 (.iL). Dilute the spore suspension out to
10"7in PBS-T.

p. Spread-plate 0.1 mL of the 10"6 and 10"7 dilutions on BH1Y-HT in
duplicate.

q. Once the inocula have dried, invert plates and incubate
anaerobically at 36±1°C for 48±4 h. Record the number of
CFlJ/plate. The titer should be >108 spores/mL. Store spore
suspension at 2-8°C for up to 5 days prior to purification.

r. Streak one BH1Y-HT plate for isolation to check for culture purity
of the spore suspension. Invert plate and incubate anaerobically at
36±1°C for 48±2 h along with the titer plates. Observe BH1Y-HT
plate for purity, colony morphology, and characteristics of C.

difficile.

12.3 Spore Purification

a.	Prepare a 50% (w/v) solution of HistoDenz™ in sterile deionized
water (11.2.k) and pi pet 5 mL into each of four sterile 15 mL
plastic conical tubes. Bring the HistoDenz™ and the spore
preparation to room temperature before use.

b.	Layer 1 mL of spore suspension (12.2.m) on top of each of the
four tubes of HistoDenz™. Centrifuge tubes at 4,500 g for 10


-------
SOP No. MB-28-08
Date Revised 09-20-22
Page 12 of 18

min using a swinging bucket rotor. Use of a swinging bucket rotor
is essential for proper layer removal and spore retention.

c.	Following centrifugation, three distinct layers should be present in
the HistoDenz™. Using a 1 niL pi pet, carefully remove the top
three layers: 1) an upper clear layer, 2) a dense (opaque) second
layer, and 3) a cloudy third layer. Discard the top three layers,
leaving the pellet and the 3 to 4 mm cloudy layer above the pellet
undisturbed.

d.	Using a repetitive pipetting action, resuspend and mix the pellet
(without touching the pellet) with a 1 niL micropipette. Bring the
volume up to approximately 1 niL with sterile cold (2-8°C) PBS-
T.

e.	Mix thoroughly by vortexing (30±5 s) to break up the pellet
(ensure absence of visual clumps or fragments of the pellet) and
transfer the contents of each tube to siliconized microcentrifuge
tubes.

f.	Centrifuge the microcentrifuge tubes (four total tubes) at
16,000xg for 5 min. Discard the supernatant and resuspend the
pellets in 1 niL of sterile, cold (2-8°C) PBS-T.

g.	Cap the tubes and mix by thoroughly vortexing (30±5 s) to break
up the pellets (ensure absence of visual clumps or fragments of
the pellet).

h.	Centrifuge the microcentrifuge tubes at 16,000xg for 2 min.
Discard the supernatant and resuspend the pellets in 1 niL of
sterile, cold (2-8°C) PBS-T. Cap the tubes and mix thoroughly by
vortexing to break up the pellets (ensure absence of visual clumps
or fragments of the pellet). This step is the first wash.

i.	Repeat washing procedure (12.3.h) two additional times, for a
total of three washes.

j. After the third wash, discard the supernatant and resuspend the
pellets in each microcentrifuge tube with 0.5 niL of sterile, cold
(2-8°C) PBS-T. Pool the contents of each microcentrifuge tube
into one 15 niL conical tube. This is the purified spore suspension.
The purified spore suspension may be stored at 2-8°C for up to 10
days prior to freezing.

k. Determine spore purity using procedures stated in 12.2n and

calculate purity of the spore suspension using the formula	


-------
SOP No. MB-28-08
Date Revised 09-20-22
Page 13 of 18



presented in section 13.1. The purity of spores should be >95%
(see Attachment 2).

1. Determine titer of the purified spore suspension as in 12.2o-q; use
the formula presented in 13.2 for calculations. The purified spore
suspension should be approximately 109 spores/mL.

i. Based on the titer calculated in 12.3k, it is recommended
to dilute a small aliquot (e.g., 100 |iL) of the purified spore
suspension with sterile PBS-T to achieve a concentration
of approximately 5.0xl08 spores/mL. Determine titer of
spores from the diluted aliquot by making serial dilutions
of the aliquot out to 10"6 and plate 0.1 mL from 10"5 and
10"6 dilutions on BH1Y-HT plates in duplicate. Incubate
plates anaerobically for 48±4 h at 36±1°C. Record the
number of CFU and calculate the titer.

m. Dilute the purified spore suspension targeting a titer of 5.Ox 108
spores/mL.

n. Determine the titer of the diluted purified spore suspension from
12.3m. Attain a titer of approximately 5.0x 108 spores/mL.

o. Streak one BH1Y-HT plate for isolation to check for culture purity
of the purified spore suspension. Invert plate and incubate
anaerobically at 36±1°C for 48±4 h along with the titer plates.
Observe BH1Y-HT plates for purity, colony morphology, and
characteristics of C. difficile. For confirmatory purposes, conduct
biochemical and antigenic analyses or other comparable
confirmation procedures (e.g., Vitek).

12.4 Long Term Spore
Storage

a.	Assign a preparation number to the final spore suspension.

b.	Freeze spores within 10 days of purification (step 12.3j). Aliquot
the diluted purified spore suspension into cryovials (-0.5 mL/vial)
and store at -80±5°C. Store/use frozen spores for up to 90 days.
Each cryovial is for single use only.

12.5 Spore

Qualification

a.	Within 2-10 days of storage, qualify the frozen spore suspension
by conducting the Quantitative Method for Testing Antimicrobial
Agents against Spores of C. difficile on Hard, Non-porous
Surfaces (SOP MB-31) using two concentrations of reagent grade
NaOCl.

b.	Using sterile deionized water as the diluent, prepare 5,000±250
ppm and 1,500±150 ppm solutions of NaOCl.


-------
SOP No. MB-28-08
Date Revised 09-20-22
Page 14 of 18



c.	Verify the concentration of the NaOCl solutions using an
appropriate titration procedure prior to use. Use NaOCl solutions
within 3 h of preparation.

d.	Refer to sections 12.2 and 12.3 of SOP MB-31 for preparation of
final spore suspension (with three-part soil load) and inoculation
and drying of carriers, respectively.

e.	Inoculate a minimum of eleven carriers (e.g., three for each
concentration of NaOCl, three for control, and two extras).

f.	Use sterile PBS-T with 0.1% (w/v) sodium thiosulfate as the
neutralizer and a contact time of 3 min ±5 s at room temperature

(22±2°C).

i. Confirm the effectiveness of the neutralizer (PBS-T with
0.1% (w/v) sodium thiosulfate) against 5,000 ppm NaOCl
using the procedure in SOP MB-31.

g.	The mean logio density for control carriers is 6.0-7.0
spores/carrier.

h.	Serially dilute the 10° tube (vial containing the carrier) for each
treatment (e.g., out to 10"1 for 5,000 ppm and out to 10"5 for 1,500
ppm) and filter the following dilutions:

i.	5,000 ppm: 10° and 10"'

ii.	1,500 ppm: 10"3, 10"4 and 10"5

i.	Record the appropriate number of CFU per filter (e.g., up to 200
CFU) and calculate the logio reduction.

j. The spore suspension is qualified if the following logio reduction
values are observed:

i.	5,000 ppm: >5.0

ii.	1,500 ppm: <3.0

iii.	If these LR values are not observed, the spores are not
deemed acceptable for testing.

12.6 Acceptance
criteria

a. The spore suspension is acceptable for use if all required criteria
have been met:

i.	Spore titer of approximately 5.Ox 108 spores/mL.

ii.	Mean spore purity of >95%.

iii.	Mean LR against two concentrations of NaOCl (>5.0 for
5,000 ppm and <3.0 for 1,500 ppm).


-------
SOP No. MB-28-08
Date Revised 09-20-22
Page 15 of 18

13. Data Analysis/
Calculations

1.	Determine spore suspension purity:

A

% Purity = 100 % x	

J A+B

Where A = mean spore count, and B = mean vegetative cell count.

2.	Determine the titer of vegetative cultures and spore suspensions
(CFlJ/mL):

A x B

Titer as CFU/mL = —-—

Where A = mean colony count at dilution plated, B = reciprocal of
dilution used, and C = volume plated.

14. Forms and Data
Sheets

1.	Attachment 1: Sporulation of C. difficile.

2.	Attachment 2: Purified C. difficile spores.

3.	Test Sheets: Test sheets are stored separately from the SOP under the
following file names:

C. difficile Spore Titer Form MB-28-08 Fl.docx

Organism Culture Tracking Form MB-28-08 F2.docx

Test Microbe Confirmation Sheet (Quality t-, 1
„ 1X MB-28-08 F3.docx
Control) -

C. difficile Vegetative Frozen Stock Culture . ..r, ™ r- < <

• . 01 & MB-28-08 F4.docx
Processing Sheet -

C. difficile Spore Suspension Initiation »-,n or, <
n ¦ J, MB-28-08 FS.docx
Processing Sheet -

C difficile Spore Suspension Harvesting MB_28_08 F6 docx

Processing Sheet -

C. difficile Spore Suspension Purification »-,n or, t-7 <
n ¦ J, MB-28-08 F7.docx
Processing Sheet -

QM for C.d.: Test Information Sheet MB-31 F1 .docx

QM for C.d.: Time Recording, Dilution and ,, ,
Filtration Sheet MB-31_F2 docx

QM for C.d.: Results Sheet MB-31 F3.docx
QM for C.d.: Test Microbe Confirmation Sheet MB-31 F4.docx
QM for C.d.: Processing Sheet MB-31 F5.docx

15. References

1. ASTM E2839-21, Standard Practice for Production and Storage of


-------
SOP No. MB-28-08
Date Revised 09-20-22
Page 16 of 18

Spores of C. difficile for Use in Efficacy Evaluation of Antimicrobial
Agents. ASTM International, West Conshohocken, PA, 2021.

2. Hasan, J. A., Japal, K. M., Christensen, E. R. and Samalot-Freire, L.
C., "Development of methodology to generate Clostridium difficile
spores for use in the efficacy evaluation of disinfectants, a pre-
collaborative investigation," J. AO AC Int, Vol 94, 201 1, pp. 259-272.


-------
SOP No, MB-28-08
Date Revised 09-20-22
Page 17 of 18

Attachment 1

Sporulation of C. difficile (ATCC 43598) during incubation at 36±1°C using phase contrast
microscopy (magnification 1000X)


-------
Attachment 2

SOP No. MB-28-08
Date Revised 09-20-22
Page 18 of 18

Purified C. difficile spores (ATCC 43598), using HistoDenz™ (>95% purity; magnification
1000X)


-------